{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:24:44Z","timestamp":1787167484728,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00115-024-01687-5","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T13:01:26Z","timestamp":1718197286000},"page":"797-802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stimulanzien","Stimulants"],"prefix":"10.1007","volume":"95","author":[{"given":"Patrick","family":"Bach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Stenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen D","family":"Ersche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"1687_CR1","volume-title":"Kompendium der Psychiatrischen Pharmakotherapie","author":"O Benkert","year":"2016","unstructured":"Benkert\u00a0O, Hippius\u00a0H (2016) Kompendium der Psychiatrischen Pharmakotherapie. Springer Berlin Heidelberg"},{"key":"1687_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-016-0370-x","volume":"5","author":"M Bhatt","year":"2016","unstructured":"Bhatt\u00a0M, Zielinski\u00a0L, Baker-Beal\u00a0L et\u00a0al (2016) Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a\u00a0systematic review and meta-analysis. Syst Rev 5:1\u201317","journal-title":"Syst Rev"},{"key":"1687_CR3","unstructured":"Bundesministerium F\u00fcr Gesundheit (2018) Drogen- und Suchtbericht. Bundesministerium f\u00fcr Gesundheit, Berlin"},{"key":"1687_CR4","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","volume":"34","author":"B Chan","year":"2019","unstructured":"Chan\u00a0B, Kondo\u00a0K, Freeman\u00a0M et\u00a0al (2019) Pharmacotherapy for Cocaine Use Disorder\u2014a Systematic Review and Meta-analysis. J\u00a0GEN INTERN MED 34:2858\u20132873","journal-title":"J GEN INTERN MED"},{"key":"1687_CR5","unstructured":"Drogenbeauftragte Der Bundesregierung (2017)  S3-Leitlinie Methamphetamin-bezogene St\u00f6rungen, Springer, Berlin"},{"key":"1687_CR6","doi-asserted-by":"publisher","first-page":"694863","DOI":"10.3389\/fpsyt.2021.694863","volume":"12","author":"A Fiorentini","year":"2021","unstructured":"Fiorentini\u00a0A, Cant\u00f9\u00a0F, Crisanti\u00a0C et\u00a0al (2021) Substance-Induced Psychoses: An Updated Literature Review. Front Psychiatry 12:694863","journal-title":"Front Psychiatry"},{"key":"1687_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jacc.2017.05.014","volume":"70","author":"O Havakuk","year":"2017","unstructured":"Havakuk\u00a0O, Rezkalla\u00a0SH, Kloner\u00a0RA (2017) The Cardiovascular Effects of Cocaine. J\u00a0Am Coll Cardiol 70:101\u2013113","journal-title":"J Am Coll Cardiol"},{"key":"1687_CR8","doi-asserted-by":"publisher","first-page":"e2322650","DOI":"10.1001\/jamanetworkopen.2023.22650","volume":"6","author":"SE Mccabe","year":"2023","unstructured":"Mccabe\u00a0SE, Schulenberg\u00a0JE, Wilens\u00a0TE et\u00a0al (2023) Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit\/Hyperactivity Disorder During Adolescence. Jama Netw Open 6:e2322650","journal-title":"Jama Netw Open"},{"key":"1687_CR9","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.2174\/1570159X19666210803091637","volume":"19","author":"A Moszczynska","year":"2021","unstructured":"Moszczynska\u00a0A (2021) Current and Emerging Treatments for Methamphetamine Use Disorder. Curr Neuropharmacol 19:2077\u20132091","journal-title":"Curr Neuropharmacol"},{"key":"1687_CR10","volume-title":"The Modulatory Effects of Atomoxetine on Aberrant Connectivity During Attentional Processing in Cocaine Use Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging","author":"LJ Nestor","year":"2023","unstructured":"Nestor\u00a0LJ, Luijten\u00a0M, Ziauddeen\u00a0H et\u00a0al (2023) The Modulatory Effects of Atomoxetine on Aberrant Connectivity During Attentional Processing in Cocaine Use Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"1687_CR11","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00213-017-4643-4","volume":"234","author":"L Passamonti","year":"2017","unstructured":"Passamonti\u00a0L, Luijten\u00a0M, Ziauddeen\u00a0H et\u00a0al (2017) Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals. Psychopharmacology 234:2289\u20132297","journal-title":"Psychopharmacology"},{"key":"1687_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamapsychiatry.2020.0246","volume":"77","author":"MP Paulus","year":"2020","unstructured":"Paulus\u00a0MP, Stewart\u00a0JL (2020) Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A\u00a0Review. Jama Psychiatry 77:959\u2013966","journal-title":"Jama Psychiatry"},{"key":"1687_CR13","first-page":"381","volume-title":"Amphetamine und Crystal Meth: Epidemiologie, Symptomatik und Therapie konsumassoziierter St\u00f6rungen. PSYCH up2date 16","author":"BB Quednow","year":"2022","unstructured":"Quednow\u00a0BB, D\u00fcrsteler\u00a0K (2022) Amphetamine und Crystal Meth: Epidemiologie, Symptomatik und Therapie konsumassoziierter St\u00f6rungen. PSYCH up2date 16, S\u00a0381\u2013397"},{"key":"1687_CR14","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1007\/978-3-030-62059-2_457","volume-title":"NeuroPsychopharmacotherapy","author":"BB Quednow","year":"2022","unstructured":"Quednow\u00a0BB, Engeli\u00a0EJE, Herdener\u00a0M (2022) Pharmacotherapy for Cocaine Use Disorders. In: Riederer\u00a0P, Laux\u00a0G, Nagatsu\u00a0T, Le\u00a0W, Riederer\u00a0C (Hrsg) NeuroPsychopharmacotherapy. Springer, Cham, S\u00a04509\u20134523"},{"key":"1687_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.01.040","volume":"150","author":"JR Richards","year":"2015","unstructured":"Richards\u00a0JR, Albertson\u00a0TE, Derlet\u00a0RW et\u00a0al (2015) Treatment of toxicity from amphetamines, related derivatives, and analogues: a\u00a0systematic clinical review. Drug Alcohol Depend 150:1\u201313","journal-title":"Drug Alcohol Depend"},{"key":"1687_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/15563650.2016.1142090","volume":"54","author":"JR Richards","year":"2016","unstructured":"Richards\u00a0JR, Garber\u00a0D, Laurin\u00a0EG et\u00a0al (2016) Treatment of cocaine cardiovascular toxicity: a\u00a0systematic review. Clin Toxicol 54:345\u2013364","journal-title":"Clin Toxicol"},{"key":"1687_CR17","doi-asserted-by":"publisher","first-page":"e0234809","DOI":"10.1371\/journal.pone.0234809","volume":"15","author":"C Ronsley","year":"2020","unstructured":"Ronsley\u00a0C, Nolan\u00a0S, Knight\u00a0R et\u00a0al (2020) Treatment of stimulant use disorder: A\u00a0systematic review of reviews. PLoS ONE 15:e234809","journal-title":"PLoS ONE"},{"key":"1687_CR18","unstructured":"Substance Abuse and Mental Health Services Administration (1999) SAMHSA\/CSAT Treatment Improvement Protocols. In: Treatment for Stimulant Use Disorders: Updated 2021. Substance Abuse and Mental Health Services Administration (US), Rockville (MD)"},{"key":"1687_CR19","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s00213-020-05563-3","volume":"237","author":"VS Tardelli","year":"2020","unstructured":"Tardelli\u00a0VS, Bisaga\u00a0A, Arcadepani\u00a0FB et\u00a0al (2020) Prescription psychostimulants for the treatment of stimulant use disorder: a\u00a0systematic review and meta-analysis. Psychopharmacology 237:2233\u20132255","journal-title":"Psychopharmacology"},{"key":"1687_CR20","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/S0140-6736(19)31205-X","volume":"393","author":"The Lancet","year":"2019","unstructured":"The Lancet (2019) ICD-11. Lancet 393:2275","journal-title":"Lancet"},{"key":"1687_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa2020214","volume":"384","author":"MH Trivedi","year":"2021","unstructured":"Trivedi\u00a0MH, Walker\u00a0R, Ling\u00a0W et\u00a0al (2021) Bupropion and naltrexone in methamphetamine use disorder. N\u00a0Engl J Med 384:140\u2013153","journal-title":"N Engl J Med"},{"key":"1687_CR22","first-page":"1","volume-title":"Handbuch Psychoaktive Substanzen","author":"M Von Heyden","year":"2017","unstructured":"Von Heyden\u00a0M (2017) Stimulanzien. In: von Heyden\u00a0M, Jungaberle\u00a0H, Maji\u0107\u00a0T (Hrsg) Handbuch Psychoaktive Substanzen. Springer Berlin Heidelberg, Berlin, Heidelberg, S\u00a01\u201326"},{"key":"1687_CR23","series-title":"cac","first-page":"4","volume-title":"Morphometric similarity deviations in stimulant use disorder point towards abnormal brain ageing. Brain Commun","author":"P Zhukovsky","year":"2022","unstructured":"Zhukovsky\u00a0P, Savulich\u00a0G, Morgan\u00a0S et\u00a0al (2022) Morphometric similarity deviations in stimulant use disorder point towards abnormal brain ageing. Brain Commun. cac, Bd. 079, S\u00a04"},{"key":"1687_CR24","volume-title":"J P","author":"U Zimmermann","year":"2021","unstructured":"Zimmermann\u00a0U (2021) J P. Psychische und Verhaltensst\u00f6rungen durch Amphetamine inkl. Methamphetamin und Methcathinon. In: Referenz Psychische St\u00f6rungen. Georg Thieme Verlag KG, Stuttgart"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-024-01687-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T09:02:38Z","timestamp":1725440558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-024-01687-5"}},"subtitle":["Aktuelle Erkenntnisse zu Grundlagen, Diagnostik und Therapie","Current insights into the principles, diagnostics and treatment"],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1687"],"URL":"https:\/\/doi.org\/10.1007\/s00115-024-01687-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"13 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Bach, M.\u00a0Stenger und K.D.\u00a0Ersche geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}